AZ reports stellar results for Lynparza in pancreatic cancer - PMLiVE
 

AZ reports stellar results for Lynparza in pancreatic cancer PMLiVEAstraZeneca and Merck & Co/MSD have caused a stir at the ASCO congress in Chicago with new data for their PARP inhibitor Lynparza in pancreatic cancer â?? a ...

View full coverage on Google News

أكثر...